May 22, 2024

Menstrual Cramps Treatment Market Propelled by Increasing Adoption of Over-the-counter Medications

Menstrual cramps, also known as period pain or dysmenorrhea, refers to pain in the lower abdomen that occurs around the time of menstruation. Common symptoms include lower abdominal pain, backache, tiredness, headache, diarrhea, and nausea. Nonsteroidal anti-inflammatory drugs (NSAIDs) and combination drugs are commonly used medications to provide relief from menstrual cramps and manage associated symptoms. Non-prescription over-the-counter drugs are gaining popularity as they offer quick and convenient pain relief without a prescription. The global Menstrual Cramps Treatment Market is estimated to be valued at US$ 652.03 Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends
Increasing Adoption of Over-the-counter Medications
The growing preference for self-medication and over-the-counter drugs for menstrual cramp relief is a key trend in the market. Historically, prescription drugs were more commonly used to manage menstrual cramps. However, women are increasingly choosing convenient OTC options to get quick relief from period pain symptoms without needing to visit a doctor. Various NSAIDs and combination analgesics formulations are freely available without prescription which women can buy directly from retail pharmacies. The easy availability and affordability of OTC menstrual drug products is contributing to their rising popularity globally.
SWOT Analysis
Strength: The menstrual cramps treatment market offers various treatment options for pain relief during menstruation. This wide range of options allows women to choose treatment best suited for their needs and symptoms.

Weakness: Some treatment options like certain pharmaceutical drugs can cause side effects in some women like nausea, headache, diarrhea etc. This limits the use of such options for all women.

Opportunity: Growing awareness about managing menstrual pain and its impact on quality of life and work presents an opportunity for companies to educate more women and promote emerging treatment solutions.

Threats: Low treatment seeking rate in some regions due to social barriers, myths and stigma around menstruation poses challenges for market growth in those areas. Strict regulations for new drugs and devices can also delay market introduction of innovative products.

Key Takeaways
The global menstrual cramps treatment market is expected to witness high growth. Various treatment options have evolved over the years providing effective period pain relief. Pharmaceutical drugs continue to dominate the market currently due to easy accessibility and affordable cost. However, demand for alternative treatments like heating pads, massage therapy and medical devices is growing steadily driven by preference for drug-free solutions and side effect concerns with medicines.

Regional analysis: North America accounts for the largest share of the global menstrual cramps treatment market currently due to high awareness levels, favorable reimbursement policies and presence of major players. Asia Pacific region is poised to witness fastest growth owing to improving access to feminine hygiene products, increasing disposable incomes in developing nations and expanding medical tourism.

Key players operating in the menstrual cramps treatment market are Stryker Corporation, SATELEC (Actongroup), Surgiform Innovative Surgical Products, Allergan (Abbvie) Luminera, Implantech, Koken, ANTHONY PRODUCTS INC., NOUVAG, Sihuan Pharmaceutical Holdings Group Ltd.


  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it